AUPM864894A0
(en )
1994-11-03
Treatment of bowel-dependent neurological disorders
PL348817A1
(en )
2002-06-17
Compositions and methods for the treatment of anorectal disorders
GB9411080D0
(en )
1994-07-20
Treatment
EP1063990A4
(en )
2003-01-02
Therapy of estrogen-associated disorders
GB0015235D0
(en )
2000-08-16
Compositions for the treatment of skin and anorectal conditions
ZA958725B
(en )
1997-04-16
Treatment of disorders with duloxetine
AU2058697A
(en )
1997-09-16
Treatment of sleep disorders
EP1030663A4
(en )
2002-06-26
Treatment of fibromyalgia and related disorders
GB9418762D0
(en )
1994-11-02
Use of substituted cyclopentane-DI-and-triones
HU9700071D0
(en )
1997-02-28
Use of muramilpeptides
PL332313A1
(en )
1999-08-30
Application of benzopyranoles in treatment of neurological disorders
GB9410512D0
(en )
1994-07-13
Novel treatment
GB9518887D0
(en )
1995-11-15
Treatment of muscular disorders
IL131347A0
(en )
2001-03-19
Treatment of skin disorders
GB9411635D0
(en )
1994-08-03
Novel treatment
EP0782631A4
(en )
1999-03-24
Treatment of plasmodium
ZA95511B
(en )
1996-03-11
Treatment of anorectal disorders
GB9415901D0
(en )
1994-09-28
Novel compounds and treatment
GB9415900D0
(en )
1994-09-28
Novel compounds and treatment
AUPM639594A0
(en )
1994-07-14
Treatment of anorectal disorders
GB9400600D0
(en )
1994-03-09
Treatment of motion seckness
GB9415902D0
(en )
1994-09-28
Method of treatment
AU7454594A
(en )
1995-03-22
Treatment of anorectal disorders
GB2285936B
(en )
1997-10-15
Treatment of fluids
GB9424471D0
(en )
1995-01-18
Treatment of emesis